ImmTOR: Chronic Refractory
Gout Therapy
ImmTOR powers sustained efficacy of pegadricase for chronic refractory gout, a debilitating disease that affects approximately 160,000 people in the United States.
ImmTOR: Gene Therapy
Selecta Biosciences has generated preclinical evidence for the potential of ImmTOR to extend the benefits of gene therapy.